Shark Tank India judge Namita Thapar is reportedly poised to gain around ₹127 crore through the IPO of Emcure Pharmaceuticals. Namita, who is a part of Emcure's promoter group, will offload about 12.68 lakh shares under the offer-for-sale component of the IPO. The public issue will open for subscription on July 3 and the price band is ₹960-1,008 per share.